Cite

HARVARD Citation

    Hu, D. et al. (2022). Mutation profiles in circulating cell‐free DNA predict acquired resistance to olaparib in high‐grade serous ovarian carcinoma. Cancer science. 113 (8), pp. 2849-2861. [Online]. 
  
Back to record